Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Stephens

Showing results (271-280 of 564) with videos related to

Pageof 57
Sort By:
Scientific Reports|November 8, 2016
Disaster declarations associated with bushfires, floods and storms in New South Wales, Australia between 2004 and 2014T Sewell, R E Stephens, D Dominey-Howes, et al.
Cardiovascular Engineering and Technology|November 10, 2025
Development and Characteristics of a Dual-Layered Vascular PhantomKaitlyn M Elmer, Cassidy Caffin, Breeanna Scott, et al.
Cell Adhesion and Communication|June 1, 2000
Expression of a soluble functional form of the integrin alpha4beta1 in mammalian cellsP E Stephens, S Ortlepp, V C Perkins, et al.
Parasitology|February 26, 2011
In vitro effects of arylimidamides against Besnoitia besnoiti infection in Vero cellsH C E Cortes, N Muller, D Boykin, et al.
European Journal of Immunology|March 1, 1995
Antibodies that activate beta 2 integrins can generate different ligand binding statesS Ortlepp, P E Stephens, N Hogg, et al.
Archives of Psychiatric Nursing|October 9, 2020
Advances in geropsychiatric nursing: A decade in reviewCaroline E Stephens, Lauren Massimo, Melodee Harris, et al.
The Journal of General Virology|January 1, 1994
Expression, characterization and purification of simian immunodeficiency virus soluble, oligomerized gp160 from mammalian cellsA D Rhodes, M Spitali, G Hutchinson, et al.
Biochemistry|October 6, 2005
Interaction of heterochromatin protein 2 with HP1 defines a novel HP1-binding domainGena E Stephens, Elizabeth E Slawson, Carolyn A Craig, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 30, 2016
Patient-reported problematic symptoms in an ALS treatment trialDivisha Raheja, Helen E Stephens, Erik Lehman, et al.
Immunology and Cell Biology|September 8, 2018
Early-life exposure to gut microbiota from disease-protected mice does not impact disease outcome in type 1 diabetes susceptible NOD miceJane A Mullaney, Juliette E Stephens, Brooke E Geeling, et al.
Pageof 57

Showing results (271-280 of 564) with videos related to

Sort By:
Pageof 57
Scientific Reports|November 8, 2016
Disaster declarations associated with bushfires, floods and storms in New South Wales, Australia between 2004 and 2014T Sewell, R E Stephens, D Dominey-Howes, et al.
Cardiovascular Engineering and Technology|November 10, 2025
Development and Characteristics of a Dual-Layered Vascular PhantomKaitlyn M Elmer, Cassidy Caffin, Breeanna Scott, et al.
Cell Adhesion and Communication|June 1, 2000
Expression of a soluble functional form of the integrin alpha4beta1 in mammalian cellsP E Stephens, S Ortlepp, V C Perkins, et al.
Parasitology|February 26, 2011
In vitro effects of arylimidamides against Besnoitia besnoiti infection in Vero cellsH C E Cortes, N Muller, D Boykin, et al.
European Journal of Immunology|March 1, 1995
Antibodies that activate beta 2 integrins can generate different ligand binding statesS Ortlepp, P E Stephens, N Hogg, et al.
Archives of Psychiatric Nursing|October 9, 2020
Advances in geropsychiatric nursing: A decade in reviewCaroline E Stephens, Lauren Massimo, Melodee Harris, et al.
The Journal of General Virology|January 1, 1994
Expression, characterization and purification of simian immunodeficiency virus soluble, oligomerized gp160 from mammalian cellsA D Rhodes, M Spitali, G Hutchinson, et al.
Biochemistry|October 6, 2005
Interaction of heterochromatin protein 2 with HP1 defines a novel HP1-binding domainGena E Stephens, Elizabeth E Slawson, Carolyn A Craig, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 30, 2016
Patient-reported problematic symptoms in an ALS treatment trialDivisha Raheja, Helen E Stephens, Erik Lehman, et al.
Immunology and Cell Biology|September 8, 2018
Early-life exposure to gut microbiota from disease-protected mice does not impact disease outcome in type 1 diabetes susceptible NOD miceJane A Mullaney, Juliette E Stephens, Brooke E Geeling, et al.
Pageof 57